U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660289) titled 'Combined Advanced Targeted Therapy for Inflammatory Bowel Disease' on June 16.
Brief Summary: The aim of this retrospective and prospective observational study is to investigate and compare the real-world effectiveness and safety of different dual-target combination therapies in patients with inflammatory bowel disease (IBD).
The key questions to be addressed are:
In patients with refractory IBD who receive either two biologic agents or one biologic agent plus one small molecule drug, what is the real-world effectiveness and safety of different combination regimens?
The researchers will conduct a retrospective analysis of medical...